Parenteral Nutrition Market Synopsis:
Parenteral Nutrition Market Size Was Valued at USD 8.54 Billion in 2023 and is Projected to Reach USD 14.48 Billion by 2032, Growing at a CAGR of 6.04 % From 2024-2032.
The Parenteral Nutrition Market refers to the sector focused on the provision of specialized nutritional support delivered directly into the bloodstream through intravenous (IV) therapy, bypassing the digestive system entirely. This form of nutrition is essential for patients who cannot consume food orally or absorb nutrients effectively due to various medical conditions such as gastrointestinal disorders, cancer, post-surgery recovery, or critical illnesses. Parenteral nutrition solutions typically consist of a carefully balanced mixture of macronutrients proteins, carbohydrates, and fats as well as micronutrients such as vitamins and minerals, tailored to meet the specific dietary needs of individual patients. The market encompasses a range of products, including Total Parenteral Nutrition (TPN) solutions, peripheral parenteral nutrition (PPN) solutions, and related medical devices, such as infusion pumps and catheter systems. Factors driving the growth of the parenteral nutrition market include the increasing prevalence of chronic diseases, a growing geriatric population, advancements in medical technology, and rising awareness about the importance of nutritional support in healthcare settings.
The market for Parenteral Nutrition has seen growth in recent years primarily due to rising need of nutrition support for the patients whom are unable to take feed orally or the patient’s GI system is not able to extract nutrients. This market consists of total parenteral nutrition (TPN) solutions, peripheral parenteral nutrition (PPN) solutions, and other peripheral infusion devices. In recent years there has been increased incidence of lifestyle related diseases including cancer, gastrointestinal disorders and metabolic disorders which increases the pool of patients that may necessitate nutritional support. Also, increase in the technological innovation about the medical field and the emerging new improved and compounded parenteral nutrition forms has continued to spur the market. The vindication of both clinical guidelines of nutritional support as well as the emphasis laid upon the multifaceted treatment plans put patients’ emphasis on the value of parenteral nutrition.
Further, the increasing demand for home healthcare services has impacted the parenteral nutrition market in a great way. With patients with chronic diseases being discharged from hospitals early and being taken care of at home by health care professionals, it has become important that the parenteral nutrition comes in portable and easy to use for home use for patients to get their needs. This transition is underpinned by the modern and enhanced infusion pump technologies, and catheter systems that ensure patients and or carers are in a position to handle their nutritional therapy. The market is also experiencing strategic partnerships between the pharmaceutical industry and healthcare institutions with a view of improving the kind of parenteral nutrition available in the market. Hence, parenteral nutrition is expected to have further growth potential based on innovations, awareness of the role of enteral nutrition, and the changes in the structures of the healthcare systems.
Market Parenteral Nutrition Market Trend Analysis:
Growing Adoption of Home Parenteral Nutrition
-
Another dynamic ahead of the parenteral nutrition market is the growing popularity of Home Parenteral Nutrition (HPN) systems, which enable patients to get intravenous nutrition therapy at home. This shift has further been influenced by increasing utilization of efficient enhanced medical technologies that support transportable infusion devices in the management of patients and nutritional caregivers. With patient-centred care and cost-effective therapies being the new mantra in healthcare systems, HPN has the distinct advantage of providing nutrition support away from the expensive inpatient setting and the volume of healthcare costs associated with it.
Expansion of Nutritional Support in Emerging Markets
-
The parenteral nutrition market also offers a great opportunity to grow nutritional support services in developing countries. This is particularly true in Asia-Pacific, Latin America, and some parts of Africa where healthcare infrastructure is developing and has biotechnological access to many modern technologies there is a growing consciousness of the role of Nutritional therapy in Chronic disease management and patient survival. A lot of patients in these areas receive diagnoses that complicate parenteral nutrition and fail to obtain adequate nutrition support. Through working with local healthcare providers, pharmaceutical companies may open the door for the entry of parenteral nutrition that meets the specific needs of the populations, formulation, and information for the doctors and patients
Parenteral Nutrition Market Segment Analysis:
The parenteral Nutrition Market is Segmented on the basis of nutrition type, patient type, application, and region.
By Type, Nutrition segment is expected to dominate the market during the forecast period
-
The TPN segment holds the largest share in the parenteral nutrition market during the forecast period. TPN entails the doping of all basic nutrients into the bloodstream; carbohydrates, proteins, fats, vitamins, as well as minerals, and is useful for patients who cannot eat or who have a mal-functional intestine. The element of growth in the incidence of chronic ailments, including cancer, gastrointestinal diseases, and metabolic disorders, also fuels the growth of the TPN solutions, primarily because patients with the aforementioned diseases are likely to require long-term nutritional support. In addition, progressive innovations in TPN formulas, differentiating the nutrients depending on patient requirements, improve the organizational benefit of nutrition therapy. The need for TPN has started to get stronger due to a growing HC awareness of the need to support patient nutrition appropriately as a factor affecting outcomes, which will help the segment maintain its leadership of the overall parenteral nutrition market. Indeed, the rising popularity of home-based healthcare is also fuelling the TPN solutions market growth since patients increasingly prefer efficient methods of nutritional support at home
By Application, the Cancer segment is expected to held the largest share
-
In the parenteral nutrition market, among the various applications the Cancer segment is expected to have the largest market share out of the following segments: diabetes, renal failures, obesity, sarcopenia, and others. The high need for nutritional intervention in cancer patient care is mainly due to issues related to malnutrition as a direct result of the illness and the side effects of the various treatment processes including chemotherapy and radiation. These treatments may sometimes that may result in lowered appetite, vomiting, and changes in metabolism; it becomes a challenge for patients to meet their required nutritional needs in the normal customary ways. Consequently, parenteral nutrition especially Total Parenteral Nutrition (TPN) becomes a useful method of administering vital macronutrients and micronutrients into the patient’s bloodstream to promote his/her well-being and well-being as he/she recovers
Parenteral Nutrition Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
In the parenteral nutrition market, the North American region is expected to remain the leading region in the forecast period. It can be explained by the high rate of chronic diseases, large investments in the development of healthcare, and the highly developed legal framework in the sphere of production and sale of nutritional supplements. Related diseases such as cancer, gastrointestinal diseases, and metabolic diseases are becoming more common in the region to demand increasing demand for nutritional support. In addition, demand for parenteral nutrition products in North America is supported by existing major healthcare centres, research institutes and pharmaceutical companies which create new technologies and availability of specialized parenteral nutrition formulations according to the patient’s needs.
- Furthermore, the increasing consumption of home healthcare services in North America has expanded the need for parenteral nutrition solutions since individuals look for nutritional treatments which can be processed at home. The level of understanding of the need for nutritional support among the medical personnel and patients due to the availability of the various forms and types of nutritional solutions has increased the market, besides various governmental measures towards better health results. Also, the complex networks of distribution and supply chain and the general relations between the supplier companies involved in the manufacturing of pharmaceutical products and the healthcare institutions help in timely delivery of the Parenteral nutrition products.
Active Key Players in the Parenteral Nutrition Market:
- Abbott Laboratories (United States)
- Baxter International Inc. (United States)
- Boehringer Ingelheim (Germany)
- Fresenius Kabi AG (Germany)
- Hollister Incorporated (United States)
- International Nutrition Company (United States)
- Janssen Pharmaceuticals, Inc. (United States)
- Kabi Pharmacia (Sweden)
- Merck KGaA (Germany)
- Nestlé Health Science (Switzerland)
- Purdue Pharma L.P. (United States)
- Sanofi (France)
- Sigma-Tau Pharmaceuticals, Inc. (United States)
- Total Parenteral Nutrition (TPN) Solutions, Inc. (United States)
- Zoetis Inc. (United States) Other Active Players
|
Global Parenteral Nutrition Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 8.54 Billion |
|
Forecast Period 2024-32 CAGR: |
6.04 % |
Market Size in 2032: |
USD 14.48 Billion |
|
Segments Covered: |
By Nutrition Type |
|
|
|
By Patient type |
|
||
|
By Application |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Parenteral Nutrition Market by Nutrition Type
4.1 Parenteral Nutrition Market Snapshot and Growth Engine
4.2 Parenteral Nutrition Market Overview
4.3 Carbohydrates
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Carbohydrates: Geographic Segmentation Analysis
4.4 Lipid Emulsion
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Lipid Emulsion: Geographic Segmentation Analysis
4.5 Vitamins and Trace
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Vitamins and Trace: Geographic Segmentation Analysis
4.6 Minerals Proteins
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Minerals Proteins: Geographic Segmentation Analysis
4.7 Others
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Others: Geographic Segmentation Analysis
Chapter 5: Parenteral Nutrition Market by patient type
5.1 Parenteral Nutrition Market Snapshot and Growth Engine
5.2 Parenteral Nutrition Market Overview
5.3 Infants
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Infants: Geographic Segmentation Analysis
5.4 Adults
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Adults: Geographic Segmentation Analysis
5.5 Geriatric
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Geriatric: Geographic Segmentation Analysis
Chapter 6: Parenteral Nutrition Market by Application
6.1 Parenteral Nutrition Market Snapshot and Growth Engine
6.2 Parenteral Nutrition Market Overview
6.3 Diabetes
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Diabetes: Geographic Segmentation Analysis
6.4 Renal Failures
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Renal Failures: Geographic Segmentation Analysis
6.5 Obesity Sarcopenia
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Obesity Sarcopenia: Geographic Segmentation Analysis
6.6 Cancer
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Cancer: Geographic Segmentation Analysis
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Parenteral Nutrition Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ABBOTT LABORATORIES (UNITED STATES)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 BAXTER INTERNATIONAL INC. (UNITED STATES)
7.4 BOEHRINGER INGELHEIM (GERMANY)
7.5 FRESENIUS KABI AG (GERMANY)
7.6 HOLLISTER INCORPORATED (UNITED STATES)
7.7 INTERNATIONAL NUTRITION COMPANY (UNITED STATES)
7.8 JANSSEN PHARMACEUTICALS INC. (UNITED STATES)
7.9 KABI PHARMACIA (SWEDEN)
7.10 MERCK KGAA (GERMANY)
7.11 NESTLÉ HEALTH SCIENCE (SWITZERLAND)
7.12 PURDUE PHARMA L.P. (UNITED STATES)
7.13 SANOFI (FRANCE)
7.14 SIGMA-TAU PHARMACEUTICALS INC. (UNITED STATES)
7.15 TOTAL PARENTERAL NUTRITION (TPN) SOLUTIONS INC. (UNITED STATES)
7.16 ZOETIS INC. (UNITED STATES)
7.17 OTHER ACTIVE PLAYERS
Chapter 8: Global Parenteral Nutrition Market By Region
8.1 Overview
8.2. North America Parenteral Nutrition Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Nutrition Type
8.2.4.1 Carbohydrates
8.2.4.2 Lipid Emulsion
8.2.4.3 Vitamins and Trace
8.2.4.4 Minerals Proteins
8.2.4.5 Others
8.2.5 Historic and Forecasted Market Size By patient type
8.2.5.1 Infants
8.2.5.2 Adults
8.2.5.3 Geriatric
8.2.6 Historic and Forecasted Market Size By Application
8.2.6.1 Diabetes
8.2.6.2 Renal Failures
8.2.6.3 Obesity Sarcopenia
8.2.6.4 Cancer
8.2.6.5 Others
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Parenteral Nutrition Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Nutrition Type
8.3.4.1 Carbohydrates
8.3.4.2 Lipid Emulsion
8.3.4.3 Vitamins and Trace
8.3.4.4 Minerals Proteins
8.3.4.5 Others
8.3.5 Historic and Forecasted Market Size By patient type
8.3.5.1 Infants
8.3.5.2 Adults
8.3.5.3 Geriatric
8.3.6 Historic and Forecasted Market Size By Application
8.3.6.1 Diabetes
8.3.6.2 Renal Failures
8.3.6.3 Obesity Sarcopenia
8.3.6.4 Cancer
8.3.6.5 Others
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Parenteral Nutrition Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Nutrition Type
8.4.4.1 Carbohydrates
8.4.4.2 Lipid Emulsion
8.4.4.3 Vitamins and Trace
8.4.4.4 Minerals Proteins
8.4.4.5 Others
8.4.5 Historic and Forecasted Market Size By patient type
8.4.5.1 Infants
8.4.5.2 Adults
8.4.5.3 Geriatric
8.4.6 Historic and Forecasted Market Size By Application
8.4.6.1 Diabetes
8.4.6.2 Renal Failures
8.4.6.3 Obesity Sarcopenia
8.4.6.4 Cancer
8.4.6.5 Others
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Parenteral Nutrition Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Nutrition Type
8.5.4.1 Carbohydrates
8.5.4.2 Lipid Emulsion
8.5.4.3 Vitamins and Trace
8.5.4.4 Minerals Proteins
8.5.4.5 Others
8.5.5 Historic and Forecasted Market Size By patient type
8.5.5.1 Infants
8.5.5.2 Adults
8.5.5.3 Geriatric
8.5.6 Historic and Forecasted Market Size By Application
8.5.6.1 Diabetes
8.5.6.2 Renal Failures
8.5.6.3 Obesity Sarcopenia
8.5.6.4 Cancer
8.5.6.5 Others
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Parenteral Nutrition Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Nutrition Type
8.6.4.1 Carbohydrates
8.6.4.2 Lipid Emulsion
8.6.4.3 Vitamins and Trace
8.6.4.4 Minerals Proteins
8.6.4.5 Others
8.6.5 Historic and Forecasted Market Size By patient type
8.6.5.1 Infants
8.6.5.2 Adults
8.6.5.3 Geriatric
8.6.6 Historic and Forecasted Market Size By Application
8.6.6.1 Diabetes
8.6.6.2 Renal Failures
8.6.6.3 Obesity Sarcopenia
8.6.6.4 Cancer
8.6.6.5 Others
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Parenteral Nutrition Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Nutrition Type
8.7.4.1 Carbohydrates
8.7.4.2 Lipid Emulsion
8.7.4.3 Vitamins and Trace
8.7.4.4 Minerals Proteins
8.7.4.5 Others
8.7.5 Historic and Forecasted Market Size By patient type
8.7.5.1 Infants
8.7.5.2 Adults
8.7.5.3 Geriatric
8.7.6 Historic and Forecasted Market Size By Application
8.7.6.1 Diabetes
8.7.6.2 Renal Failures
8.7.6.3 Obesity Sarcopenia
8.7.6.4 Cancer
8.7.6.5 Others
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Global Parenteral Nutrition Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 8.54 Billion |
|
Forecast Period 2024-32 CAGR: |
6.04 % |
Market Size in 2032: |
USD 14.48 Billion |
|
Segments Covered: |
By Nutrition Type |
|
|
|
By Patient type |
|
||
|
By Application |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
